Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Morrissey

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
The Journal of Antimicrobial Chemotherapy|January 20, 2004
Activity of gemifloxacin against Streptococcus pneumoniae and Haemophilus influenzaeIan Morrissey, Glenn Tillotson
The Journal of Antimicrobial Chemotherapy|February 24, 2012
Activity of ceftaroline against serotyped Streptococcus pneumoniae isolates from Europe and South Africa associated with community-acquired bacterial pneumonia (2007-08)Ian Morrissey, Anne Leakey
The Journal of Antimicrobial Chemotherapy|August 8, 2007
Activity of iclaprim against Legionella pneumophilaIan Morrissey, Stephen Hawser
The Journal of Antimicrobial Chemotherapy|September 19, 2025
Modification of antimicrobial susceptibility testing methodsIan Morrissey, Jean B Patel
International Journal of Antimicrobial Agents|February 11, 2009
Activity of the new cephalosporin ceftaroline against bacteraemia isolates from patients with community-acquired pneumoniaIan Morrissey, Yigong Ge, Regina Janes
The Journal of Antimicrobial Chemotherapy|May 12, 2009
ME1036, a novel carbapenem, with enhanced activity against clinical isolates causing bacteraemic community-acquired pneumoniaIan Morrissey, Don Biek, Regina Janes
Journal of Medical Microbiology|June 8, 2001
A comparison of the bactericidal activity of quinolone antibiotics in a Mycobacterium fortuitum modelStephen H Gillespie, Ian Morrissey, Dean Everett
International Journal of Antimicrobial Agents|July 17, 2012
In vitro activity of ceftaroline and comparator antimicrobials against European and Middle East isolates from complicated skin and skin-structure infections collected in 2008-2009Ian Morrissey, Anne Leakey, John Blackman Northwood
Antimicrobial Agents and Chemotherapy|July 25, 2003
Quinupristin-dalfopristin resistance in Streptococcus pneumoniae: novel L22 ribosomal protein mutation in two clinical isolates from the SENTRY antimicrobial surveillance programRonald N Jones, David J Farrell, Ian Morrissey
The Journal of Infection|July 9, 2004
Surveillance of the susceptibility of ocular bacterial pathogens to the fluoroquinolone gatifloxacin and other antimicrobials in Europe during 2001/2002Ian Morrissey, Ray Burnett, Louise Viljoen, et al.
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
The Journal of Antimicrobial Chemotherapy|January 20, 2004
Activity of gemifloxacin against Streptococcus pneumoniae and Haemophilus influenzaeIan Morrissey, Glenn Tillotson
The Journal of Antimicrobial Chemotherapy|February 24, 2012
Activity of ceftaroline against serotyped Streptococcus pneumoniae isolates from Europe and South Africa associated with community-acquired bacterial pneumonia (2007-08)Ian Morrissey, Anne Leakey
The Journal of Antimicrobial Chemotherapy|August 8, 2007
Activity of iclaprim against Legionella pneumophilaIan Morrissey, Stephen Hawser
The Journal of Antimicrobial Chemotherapy|September 19, 2025
Modification of antimicrobial susceptibility testing methodsIan Morrissey, Jean B Patel
International Journal of Antimicrobial Agents|February 11, 2009
Activity of the new cephalosporin ceftaroline against bacteraemia isolates from patients with community-acquired pneumoniaIan Morrissey, Yigong Ge, Regina Janes
The Journal of Antimicrobial Chemotherapy|May 12, 2009
ME1036, a novel carbapenem, with enhanced activity against clinical isolates causing bacteraemic community-acquired pneumoniaIan Morrissey, Don Biek, Regina Janes
Journal of Medical Microbiology|June 8, 2001
A comparison of the bactericidal activity of quinolone antibiotics in a Mycobacterium fortuitum modelStephen H Gillespie, Ian Morrissey, Dean Everett
International Journal of Antimicrobial Agents|July 17, 2012
In vitro activity of ceftaroline and comparator antimicrobials against European and Middle East isolates from complicated skin and skin-structure infections collected in 2008-2009Ian Morrissey, Anne Leakey, John Blackman Northwood
Antimicrobial Agents and Chemotherapy|July 25, 2003
Quinupristin-dalfopristin resistance in Streptococcus pneumoniae: novel L22 ribosomal protein mutation in two clinical isolates from the SENTRY antimicrobial surveillance programRonald N Jones, David J Farrell, Ian Morrissey
The Journal of Infection|July 9, 2004
Surveillance of the susceptibility of ocular bacterial pathogens to the fluoroquinolone gatifloxacin and other antimicrobials in Europe during 2001/2002Ian Morrissey, Ray Burnett, Louise Viljoen, et al.
Pageof 7